Open AccessM13. Identifying Youths at Risk for Antipsychotic-Induced Weight Gain and Metabolic Dysfunction in the Treatment of Early Onset Schizophrenia Spectrum Disorders (TEOSS)
Author(s) -
Jerome H. Taylor,
Ewgeni Jakubovski,
Daniel Gabriel,
Michael H. Bloch
Publication year - 2017
Publication title -
schizophrenia bulletin
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.823
H-Index - 190
eISSN - 1745-1707
pISSN - 0586-7614
DOI - 10.1093/schbul/sbx022.012
Subject(s) - olanzapine , schizoaffective disorder , risperidone , antipsychotic , medicine , schizophrenia (object oriented programming) , weight gain , randomized controlled trial , randomization , psychosis , bipolar disorder , atypical antipsychotic , endocrinology , psychiatry , psychology , body weight , lithium (medication)
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom